help button home button Endocrine Society JCEM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

Journal of Clinical Endocrinology & Metabolism, doi:10.1210/jc.2007-1993
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
93/3/1072    most recent
Author Manuscript (PDF)
Right arrow Submit a related Letter to the Editor
Right arrow View responses
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Nuti, F.
Right arrow Articles by Krausz, C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Nuti, F.
Right arrow Articles by Krausz, C.
Related Collections
Right arrow Male Endocrinology
Right arrow Pediatric Endocrinology
The Journal of Clinical Endocrinology & Metabolism Vol. 93, No. 3 1072-1076
Copyright © 2008 by The Endocrine Society


BRIEF REPORT

The Leucine-Rich Repeat-Containing G Protein-Coupled Receptor 8 Gene T222P Mutation Does Not Cause Cryptorchidism

Francesca Nuti, Eliana Marinari, Edit Erdei, Manal El-Hamshari, Mirna Guadalupe Echavarria, Elisabet Ars, Giancarlo Balercia, Miklos Merksz, Claudia Giachini, Kamal Zaki Mahmoud Shaeer, Gianni Forti, Eduard Ruiz-Castané and Csilla Krausz

Andrology Unit (F.N., E.M., C.G., G.F., C.K.), Department of Clinical Physiopathology, University of Florence, 50139 Firenze, Italy; Andrology-Urology Division (E.E.), National Health Center, 1112 Budapest, Hungary; Genetic Engineering and Biotechnology Institute (M.E.-H.), Menufiya University (Molecular Diagnostics Department), Egypt; Andrology Service (M.G.E., E.A., E.R.-C., C.K.), Fundacio Puigvert, 08025 Barcelona, Spain; Division of Endocrinology (G.B.), Institute of Internal Medicine Polytechnic University of Marche, 60100 Ancona, Italy; Department of Paediatric Urology (M.M.), Heim Pál Children s Hospital, Budapest H-1089, Hungary; and Faculty of Medicine (K.Z.M.S), Cairo University, Cario, 11511, Egypt

Address all correspondence and requests for reprints to: Csilla Krausz, Andrology Unit, Department of Clinical Physiopathology, University of Florence, Viale Pieraccini 6, 50139 Firenze, Italy. E-mail: c.krausz{at}dfc.unifi.it.

Context: Insulin-like 3 and its receptor, leucine-rich repeat-containing G protein-coupled receptor 8 (LGR8), are essential for the first phase of testicular descent. Homozygous loss of either of the two genes in mice leads to cryptorchidism. Although mutations in both homologous human genes are not a common cause of cryptorchidism. To date, only one missense mutation at codon 222 (T222P) of the LGR8 gene has been proposed as a causative mutation for cryptorchidism. This conclusion was based on both functional in vitro studies and the lack of mutation in a large group of controls. The geographical origin of the mutation carriers suggested a founder effect in the Mediterranean area.

Objectives: We sought to define the frequency of the T222P mutation in four different countries to assess whether the screening for this mutation could be of use as a diagnostic genetic test.

Materials and Methods: A total of 822 subjects (359 with a history of cryptorchidism and 463 controls) from Italy, Spain, Hungary, and Egypt were genotyped for the T222P mutation by direct sequencing.

Results: The phenotypical expression of the mutation also included normal testicular descent. The mutation frequency was not significantly different in cryptorchid patients vs. noncryptorchid controls (3.6 vs. 1.7%, respectively). No significant geographical differences were observed in mutation frequencies. The haplotype analysis allowed us to predict three distinct haplotypes, i.e. three possible mutation events.

Conclusions: Our results suggest that the T222P mutation cannot be considered either causative or a susceptibility factor for cryptorchidism. A true causative mutation in the LGR8 gene still remains to be identified.




eLetters:

Read all eLetters

The LGR8 gene T222P mutation is a risk factor for cryptorchidism
Carlo Foresta, et al.
JCEM Online, 12 Jan 2008 [Full text]
Response to E-Letter
Csilla Krausz, et al.
JCEM Online, 11 Feb 2008 [Full text]



HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 2008 by The Endocrine Society